Authors: Schroeder, MC Hamby, JM Connolly, CJC Grohar, PJ Winters, RT Barvian, MR Moore, CW Boushelle, SL Crean, SM Kraker, AJ Driscoll, DL Vincent, PW Elliott, WL Lu, GH Batley, BL Dahring, TK Major, TC Panek, RL Doherty, AM Showalter, HDH

Citation: Mc. Schroeder et al., Soluble 2-substituted aminopyrido[2,3-d]pyrimidin-7-yl ureas. Structure-activity relationships against selected tyrosine kinases and exploration of in vitro and in vivo anticancer activity, J MED CHEM, 44(12), 2001, pp. 1915-1926

Authors: Cody, WL Lin, ZW Panek, RL Rose, DW Rubin, JR

Citation: Wl. Cody et al., Progress in the development of inhibitors of SH2 domains, CUR PHARM D, 6(1), 2000, pp. 59-98

Authors: Thompson, AM Rewcastle, GW Boushelle, SL Hartl, BG Kraker, AJ Lu, GH Batley, BL Panek, RL Showalter, HDH Denny, WA

Citation: Am. Thompson et al., Synthesis and structure-activity relationships of 7-substituted 3-(2,6-dichlorophenyl)-1,6-naphthyridin-2 (1H)-ones as selective inhibitors of pp60(c-src), J MED CHEM, 43(16), 2000, pp. 3134-3147

Authors: Palmer, BD Kraker, AJ Hartl, BG Panopoulos, AD Panek, RL Batley, BL Lu, GH Trumpp-Kallmeyer, S Showalter, HDH Denny, WA

Citation: Bd. Palmer et al., Structure-activity relationships for 5-substituted 1-phenylbenzimidazoles as selective inhibitors of the platelet-derived growth factor receptor, J MED CHEM, 42(13), 1999, pp. 2373-2382

Authors: Palmer, BD Smaill, JB Boyd, M Boschelli, DH Doherty, AM Hamby, JM Khatana, SS Kramer, JB Kraker, AJ Panek, RL Lu, GH Dahring, TK Winters, RT Showalter, HDH Denny, WA

Citation: Bd. Palmer et al., Structure-activity relationships for 1-phenylbenzimidazoles as selective ATP site inhibitors of the platelet-derived growth factor receptor, J MED CHEM, 41(27), 1998, pp. 5457-5465